Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-08-28
2007-08-28
Ungar, Susan (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C435S069100, C435S069700, C536S023700, C530S300000, C530S350000
Reexamination Certificate
active
10665990
ABSTRACT:
The present invention is directed to novel polypeptides, polynucleotides and vaccines for use againstNeisseria gonorrhoeaecolonization or infection and/orNeisseria meningitidiscolonization or infection. The vaccines contain an immunogenic amount of a neisserial protein.
REFERENCES:
patent: 4533630 (1985-08-01), Wilkins et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4873192 (1989-10-01), Kunkel
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 2003/0100071 (2003-05-01), Apicella et al.
patent: 0 184 187 (1986-06-01), None
patent: WO98/02547 (1998-01-01), None
patent: WO99/24578 (1999-05-01), None
patent: WO99/57280 (1999-11-01), None
patent: WO 00/71725 (2000-11-01), None
patent: WO 02/60936 (2002-08-01), None
Paz et al 1995, Microbiology 141, 913-920.
Accession No. B81859.
Accession No. AAY 75751 and Accession No. AAY 75753.
GenBank Accession No. B81859.
Alpuche-Aranda et al., “SalmonellaStimulate Macrophage Macropinocytosis and Persist within Spacious Phagosomes, ”J. Exp. Med., 1994, 179:601-608.
Altieri, “Occupancy of CDllb/CD18 (Mac-1) Divalent Ion Binding Site(s) Induces Leukocyte Adhesion,”J. Immunol., 1991, 147:1891-1898.
Altschul et al., “Basic Local Alignment Search Tool,”J. Mol. Biol., 1990, 215:403-410.
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,”Nucl. Acids Res., 1997, 25:3389-3402.
Apicella, “Antigenically Distinct Populations ofNeisseria gonorrhoeae: Isolation and Characterization of the Responsible Determinants,”J. Infect. Dis., 1974, 130:619-625.
Batzer et al., “Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus,”Nucl. Acids. Res., 1991, 19:5081.
Becherer et al., “Cell Surface Proteins Reacting with Activated Complement Components,”Complement Inflamm., 1989, 6:142-165.
Bessen and Gotschlich, “Interactions of Gonococci with HeLa Cells: Attachement, Detachment, Replication, Penetration, and the Role of Protein II,”Infect. Immun., 1986, 54:154-160.
Bjerknes et al., “Neisserial Porins Inhibit Human Neutrophil Actin Polymerization, Degranulation, Opsonin Receptor Expression, and Phagocytosis but Prime the Neutrophils To Increase Their Oxidative Burst,”Infect. Immun., 1995, 63:160-167.
Cann et al., “Detection of antibodies to common antigens of pathogenic and commensalNeisseriaspecies,”J. Med. Microbiol., 1989, 30:23-30.
Caron et al., “Identification of Two Distinct Mechanisms of Phagocytosis Controlled by Different Rho GTPases,”Science, 1998, 282:1717-1721.
Carrea et al., “Purification and properties of two phospholipases D fromStreptomycessp.,”Biochim. Biophys. Acta., 1995, 1255:273-279.
Chen et al., “Heparin Protects Opa+Neisseria gonorrhoeaefrom the Bactericidal Action of Normal Human Serum,”Infect. Immun., 1995, 63:1790-1795.
Christodoulides et al., “Interaction of primary human endometrial cells withNeisseria gonorrhoeaeexpressing green fluorescent protein,”Mol. Microbiol., 2000, 35:32-43.
Clarke and Spudich, “Nonmuscle Contractile Proteins: The Role of Actin and Myosin in Cell Motility and Shape Determination,”Ann. Rev. Biochem., 1977, 46:797-822.
Clauser et al., “Role of Accurate Mass Measurement (±10 ppm) in Protein Indentification Strategies Employing MS or MS/MS and Database Searching,”Anal. Chem., 1999, 71:2871-2882.
Clerc and Sansonetti, “Entry ofShigella flexneriinto HeLa Cells: Evidence for Directed Phagocytosis Involving Actin Polymerization and Myosin Accumulation,”Infect. Immun., 1987, 55:2681-2688.
Cohen et al., “Human experimentation withNeisseria gonorrhoeae: Rationale, Methods, and Implications for the Biology of Infection and Vaccine Development,”J. Infect. Dis., 1994, 169:532-537.
Colley et al., “Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization,”Curr. Biol., 1997, 7:191-201.
Cooper, “Complement evasion strategies of microorganisms,”Immun. Today, 1991, 12(9):327-331.
Corpet, “Multiple sequence alignment with hierarchical clustering,”Nucl Acids Res., 1988, 16:10881-10890.
Dayhoff et al., “A Model of Evolutionary Change in Proteins,”Atlas of Protein Sequence and Structure, Natl. Biomed. Res. Found., 1978, pp. 345-352.
de la Paz et al., “Effect of sialylation of lipopolysaccharide ofNeisseria gonorrhoeaeon recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens,”Microbiology, 1995, 141:913-920.
Dehio et al., “The role of neisserial Opa proteins in interactions with host cells,”Trends Microbiol., 1998, 6:489-495.
Densen et al., “Dissemination of Gonococcal Infection is Associated with Delayed Stimulation of Complement-Dependent Neutrophil Chemotaxis In Vitro,”Infection and Immunity, 1982, 38:563-572.
DiPaolo et al., “Cellular and Molecular Alterations in Human Epithelia Cells Transformed by Recombinant Human Papillomavirus DNA,”Crit. Rev. Oncogen., 1993, 4:337-360.
Dramsi and Cossart, “Intracellular Pathogens and the Actin Cytoskeleton,”Annu. Rev. Cell Dev. Biol., 1998, 14:137-166.
Draper et al., “Scanning electron microscopy of attachment ofNeisseria gonorrhoeaecolony phenotypes to surfaces of human genital epithelia,”Am. J. Obstet. Gynecol., 1980, 138:818-826.
Dudas and Apicella, “Selection and Immunochemical Analysis of Lipooligosaccharide Mutants ofNeisseria gonorrhoeae,” Infect. Immun., 1988, 56:499-504.
Edwards and Apicella, “The role of lipooligosaccharide inNeisseria gonorrhoaepathogenesis of cervical epithelia: lipid A serves as a C3 acceptor molecule,”Cell. Microbiol., 2002, 4:585-598.
Edwards et al., “A co-operative interaction betweenNeisseria gonorrhoeaeand complement receptor 3 mediates infection of primary cervical epithelial cells,”Cell. Microbiol., 2002, 4:571-584.
Edwards et al., “Complement Receptor Type 3 (CR 3) on Primary Cervical Epithelial Cells Serves as a Receptor forNeisseria Gonorrhoeae,” Abstracts of the 101stGeneral Meeting of the American Society for Microbiology, 2001, Orlando, FL, p. 303.
Edwards et al,. “The Role of Complement Receptor 3 (CR3) inNeisseria GonorrhoeaeInfection of Human Cervical Epithelia,”Cell. Microbiol., 2001, 3:611-622.
Elmer and Edgington, “Microfilament Reorganization Is Associated with Functional Activation of αMβ2on Monocytic Cells,”J. Biol. Chem., 1994, 269:3159-3166.
Erdei et al., “The role of C3 in the immune response,”Immun. Today, 1991, 12:332-337.
Evans, “Ultrastructural Study of Cervical Gonorrhea,”J. Infect. Dis., 1977, 136(2):248-255.
Exton, “New Developments in Phospholipase D,”J. Biol. Chem., 1997, 272:15579-15582.
Fällman et al., “Complement Receptor-mediated Phagocytosis Is Associated with Accumulation of Phosphatidylcholine-derived Diglyceride in Human Neutrophila,”J. Biol. Chem., 1992, 267:2656-2663.
Fijen et al., “The role of Fcγ receptor polymorphisms and C3 in the immune defense againstNeisseria meningitidisin complement-deficient individuals,”Clin. Exp. Immunol., 2000, 120:338-345.
Finlay and Falkow, “Common Themes in Microbial Pathogenicity Revisited,”Microbiol. Mol. Biol. Rev., 1997, 61:136-169.
Finlay and Ruschkowski, “Cytoskeletal rearrangements accompanyingSalmonellaentry into epithelial cells,”J. Cell Sci., 1991, 99:283-296.
Fluhmann, “The Squamocolumnar Transitional Zone of the Cervix Uteri,”Obstet. Gynecol., 1959, 14:133-148.
Francis et al., “Ruffles induced by
Apicella Michael A.
Edwards Jennifer L.
Baskar Padma
Ungar Susan
University of Iowa Research Foundation
Viksnins Harris & Padys PLLP
LandOfFree
Vaccine and compositions for the prevention and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine and compositions for the prevention and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine and compositions for the prevention and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847378